Successive Delivery Of Medicinal Products Containing The Active Substances: Prednisone, Sulfamethoxazole + Trimethoprim For The Implementation Of A Non-Commercial Clinical Trial

Medical University of Gdansk Poland has Released a tender for Successive Delivery Of Medicinal Products Containing The Active Substances: Prednisone, Sulfamethoxazole + Trimethoprim For The Implementation Of A Non-Commercial Clinical Trial in Pharmaceuticals. The tender was released on Jan 08, 2024.

Country - Poland

Summary - Successive Delivery Of Medicinal Products Containing The Active Substances: Prednisone, Sulfamethoxazole + Trimethoprim For The Implementation Of A Non-Commercial Clinical Trial

Deadline - login to view

MT reference number - 76757422

Product classification - Pharmaceutical products

Organization Details:

  Address - Poland

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 76757422

  Document Type - Tender Notices

Notice Details and Documents:

Description - The full name of the order, which did not fit in section II.1.1 of the announcement due to the limited number of characters, is: Successive delivery of medicinal products containing the active substances: prednisone (Encorton 5 mg; Encorton 10 mg; En corton 20 mg) and sulfamethoxazole + trimethoprim (Biseptol 120 mg; Biseptol 480 mg) for the purposes of conducting a non-commercial clinical trial.

Mt Ref Id - 76757422

Deadline - Nov 30, -0001

Share

Similar Tenders :